What Is NGS Testing and When Is It Needed?

Discover how next-generation sequencing (NGS) testing identifies cancer mutations, supports precision oncology and helps guide treatment decisions.

Cancer develops when cells acquire changes that affect their normal growth and division. Some of these changes, known as genetic alterations, can influence how a tumour behaves and responds to treatment.

Next-generation sequencing, commonly called NGS, is an advanced molecular testing technique that allows laboratories to examine multiple genes simultaneously.

It plays an important role in precision oncology and personalised cancer treatment.

What Is NGS Testing?

NGS is a technology used to analyse large amounts of genetic information quickly.

In cancer care, NGS can identify multiple genetic alterations in tumour DNA or RNA using a single testing approach.

Depending on the panel, it may detect:

  • Gene mutations.
  • Gene amplifications.
  • Gene deletions.
  • Gene fusions.
  • Other clinically relevant molecular alterations.

These findings may help identify potential treatment targets.

How Does NGS Testing Work?

Step 1: Sample Collection

A tumour tissue sample obtained through biopsy or surgery is commonly used. In selected situations, a blood-based liquid biopsy may be considered.

Step 2: Genetic Analysis

The laboratory extracts genetic material and examines selected genes using sequencing technology.

Step 3: Report Generation

The results identify genetic alterations and classify their potential clinical significance.

Step 4: Treatment Evaluation

A medical oncologist interprets the report alongside the cancer diagnosis, stage and other clinical findings.

When Is NGS Testing Needed?

NGS may be considered in:

Advanced Lung Cancer: To identify alterations such as EGFR, ALK, ROS1, BRAF, MET, RET, NTRK and others, depending on the cancer subtype and testing panel.

Advanced Colorectal Cancer: To evaluate relevant alterations such as RAS, BRAF and other biomarkers.

Certain Breast and Ovarian Cancers: To investigate selected molecular alterations that may guide treatment.

Rare Cancers: Molecular profiling may help identify unusual genetic changes in cancers with limited standard treatment options.

Cancer That Has Progressed After Treatment: In selected cases, molecular profiling may help identify additional treatment opportunities.

What Are the Benefits of NGS Testing?

  • Examines multiple genes simultaneously.
  • May identify actionable mutations.
  • Supports precision oncology.
  • Can help guide targeted treatment decisions.
  • May identify potential clinical trial opportunities.

Are There Any Limitations?

Yes. NGS does not guarantee that a suitable treatment will be found.

Some detected mutations may have uncertain clinical significance. Testing may also be limited by sample quality, insufficient tumour tissue or technical factors.

Additionally, not every cancer patient requires broad NGS testing.

NGS vs Traditional Molecular Testing

Traditional molecular testing may focus on one or a few specific biomarkers. NGS can examine many genes in a single test.

The most appropriate approach depends on the cancer type, available tissue, treatment guidelines and clinical requirements.

Consult a Medical Oncologist in Raipur

NGS reports can be complex and require specialist interpretation.

Dr. Ayush Dubey, Medical Oncologist in Raipur, helps patients understand molecular testing and its relevance to personalised cancer treatment.

Advanced testing is most valuable when its results can help answer an important treatment-related question.

About the Author

Leave a Reply

Your email address will not be published. Required fields are marked *

You may also like these